1290 Essex Small Cap Growth Fund Class A ESCFX

Medalist Rating as of | See 1290 Funds Investment Hub
  • NAV / 1-Day Return 18.47  /  +0.10 %
  • Total Assets 115.2M
  • Adj. Expense Ratio
    1.130%
  • Expense Ratio 1.130%
  • Distribution Fee Level Below Average
  • Share Class Type Front Load
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 55%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 3:34 AM GMT+0

Morningstar’s Analysis ESCFX

Will ESCFX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

1290 Essex Small Cap Growth A holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ESCFX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 20.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Kiniksa Pharmaceuticals International PLC Class A

2.61 3M
Healthcare

Lincoln Educational Services Corp

2.53 3M
Consumer Defensive

Leonardo DRS Inc

2.39 3M
Industrials

JPMorgan Prime Money Market IM

2.29 3M
Cash and Equivalents

Adaptive Biotechnologies Corp

2.23 3M
Healthcare

CECO Environmental Corp

2.08 2M
Industrials

Graham Corp

1.88 2M
Industrials

Argan Inc

1.86 2M
Industrials

BrainsWay Ltd ADR

1.82 2M
Healthcare

Arteris Inc

1.74 2M
Technology

Sponsor Center